NCT05047172 Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05043090 Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05033431 Study to Evaluate the Pharmacokinetics (Movement of Drugs Within the Body), Safety and Tolerability of Brazikumab in Healthy Chinese and White Participants Status COMPLETED Phase PHASE1
NCT05008913 Human Absorption, Distribution, Metabolism, and Excretion Study of [14C]Adavosertib Status TERMINATED Phase PHASE1
NCT05008055 Study of Capivasertib in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Status COMPLETED Phase PHASE2
NCT05007275 A Study to Determine Safety and Immunogenicity of the Candidate COVID-19 Vaccine AZD1222 Delivered by Aerosol in Healthy Adult Volunteers Status UNKNOWN Phase PHASE1
NCT05006573 Efficacy and Safety of Benralizumab in Patients With Non-cystic Fibrosis Bronchiectasis Status TERMINATED Phase PHASE3
NCT05004064 Acalabrutinib and Rituximab in Previously Untreated Mantle Cell Lymphoma Status RECRUITING Phase PHASE2
NCT05001698 Anifrolumab PK Study for Systemic Lupus Erythematosus (SLE) Status COMPLETED Phase PHASE1
NCT05000710 Concomitant Radiotherapy, Tremelimumab & Durvalumab for Advanced NSCLC Patients Progressing on First-line Immunotherapy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04999969 Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04997161 Study of SZC and Enhanced Nutrition Advice Compared to SoC in Dialysis Patients With Hyperkalaemia Status TERMINATED Phase PHASE4
NCT04995523 A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04994106 A Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD5462 Following Single and Multiple Ascending Dose Administration to Healthy Volunteers Status COMPLETED Phase PHASE1
NCT04991805 Descriptive Study of the Incidence of Malignancy in Severe Asthma Patients Receiving Benralizumab and Other Biologic Therapy, a Post Authorization Safety Study Status COMPLETED Phase N/A
NCT04991571 Study to Collect Samples for MIST Analysis of Zibotentan and Bioavailability of Zibotentan and Dapagliflozin in Heatlhy Participants Status COMPLETED Phase PHASE1